Here is what you need to know on Wednesday, August 5:
Stocks, bonds, and precious metals are on the rise while the greenback is falling alongside falling yields. Investors are eyeing slow progress in fiscal stimulus talks and top-tier US figures ahead of the Non-Farm Payrolls.
Gold has surged through $2,000, hitting a new all-time high of $2,030.85 before consolidating its gains on high ground. The precious metal is underpinned by fiscal and monetary stimulus, with the latest drive higher going hand in hand with the drop in global bond yields.
The return on ten-year US Treasuries is closer to 0.50%, nearing March's lows. Yieldless gold looks more attractive on this background. Silver prices are also on the rise, with XAG/USD hitting $26.
See Hot Summer In Markets: Gold, silver, euro, and dollar volatility explained
US Fiscal stimulus: While Republicans and Democrats say they are far apart, they hope to reach a deal in the next few days and report making progress "bit by bit."
Sino-American relations: Trade negotiators from the world's largest economies will hold a meeting to assess how Phase One of the commerce accord is moving forward. Such meetings are a positive development after long weeks of clashes around a long list of issues.
ADP's labor report is set to show an increase of over one million private-sector jobs in July. The publication will help shape expectations for the official Non-Farm Payrolls, even though the correlation has been lacking in recent months.
See US ADP Employment Change July Preview: Following the high-frequency data
The ISM Non-Manufacturing Purchasing Managers' Index is forecast to decrease from 57.1 points in June but remains in growth territory. Apart from the headline figure, the employment component is closely watched as well, ahead of the jobs report. It is essential to note that the Manufacturing PMI beat on the headline but exposed a soft job market.
See US Non-Manufacturing PMI July Preview: Second thoughts on the US economy
Vaccine hopes: Novavax, a Maryland-based company, has been the latest to publish promising results in developing immunization for coronavirus. It joins a long list of companies, armed with funding from the US government.
US coronavirus: The case curve continues bending lower, an encouraging development. However, deaths returned to topping 1,000 per day after the weekend effect faded away.
EUR/USD has topped 1.18 once again, driven by dollar weakness. Final services PMIs are set to confirm the recovery in July.
GBP/USD is trading closer to 1.31, as the British government is criticized for keeping borders open for too long at the beginning of the coronavirus crisis.
NZD/USD is trading above 0.66, mostly benefiting from the greenback's weakness but also underpinned by a lower-than-expected jobless rate in New Zealand – only 4% in the second quarter.
USD/CAD has dropped below 1.33, also pushed higher by the small increase in WTI Oil, which is around $41.50. Oil Inventories are due out later in the day.
Cryptocurrencies have stabilized on higher ground after several volatile days, with Bitcoin trading well above $11,000.
More Where next for the dollar, stocks and the US economy after downbeat data and the Fed
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD extends gains above 1.0700, focus on key US data
EUR/USD meets fresh demand and rises toward 1.0750 in the European session on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data.
USD/JPY keeps pushing higher, eyes 156.00 ahead of US GDP data
USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, recapturing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming intervention risks. The focus shifts to Thursday's US GDP report and the BoJ decision on Friday.
Gold closes below key $2,318 support, US GDP holds the key
Gold price is breathing a sigh of relief early Thursday after testing offers near $2,315 once again. Broad risk-aversion seems to be helping Gold find a floor, as traders refrain from placing any fresh directional bets on the bright metal ahead of the preliminary reading of the US first-quarter GDP due later on Thursday.
Injective price weakness persists despite over 5.9 million INJ tokens burned
Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price.
US Q1 GDP Preview: Economic growth set to remain firm in, albeit easing from Q4
The United States Gross Domestic Product (GDP) is seen expanding at an annualized rate of 2.5% in Q1. The current resilience of the US economy bolsters the case for a soft landing.